Who
Erez Aminov
CEO and Chairman
Company insider
Files Form 4 as: CEO and Chairman, Telomir Pharmaceuticals; Chief Executive Officer, MIRA Pharmaceuticals.
In numbers
- Trades disclosed
- 44
- Buys
- 1
- Sells
- 4
- Bought
- $8,176
- Sold
- $1.4M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 17 Aug 2023
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,960,170 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,960,170 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000,000 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,960,170 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,960,170 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000,000 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000,000 | filing |
| 21 May 2026filed 22 May 2026 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000,000 | filing |
| 22 Apr 2026filed 24 Apr 2026 | TELO Telomir PharmaceuticalsBiotechnology | SEC FORM 4 Code J | $10.0M7,319,710 at $1.37 | filing |
| 22 Apr 2026filed 24 Apr 2026 | TELO Telomir PharmaceuticalsBiotechnology | SEC FORM 4 Code J | $10.0M7,319,710 at $1.37 | filing |
| 30 Mar 2026filed 1 Apr 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,500 at $0.00 | filing |
| 30 Mar 2026filed 1 Apr 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,500 at $0.00 | filing |
| 17 Dec 2025filed 17 Feb 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,155,170 at $0.00 | filing |
| 16 Oct 2025filed 17 Feb 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —234,595 at $0.00 | filing |
| 16 Oct 2025filed 17 Feb 2026 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —379,000 at $0.00 | filing |
| 16 Oct 2025filed 17 Feb 2026 | MIRA MIRA PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $272K234,595 at $1.16 | filing |
| 16 Oct 2025filed 17 Feb 2026 | MIRA MIRA PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $318K379,000 at $0.84 | filing |
| 16 Oct 2025filed 17 Feb 2026 | MIRA MIRA PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1.3M613,595 at $2.11 | filing |
| 1 Oct 2025filed 3 Oct 2025 | MIRA MIRA PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,685,456 | filing |
| 18 Sep 2025filed 18 Sep 2025 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
News
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the CompanyTELO · manilatimes.net · 6 Oct 2026
0 headlines in the last 90 days name Erez Aminov; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.